Literature DB >> 7511818

Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta.

V Vieillard1, E Lauret, V Rousseau, E De Maeyer.   

Abstract

We are developing methods for somatic-cell gene therapy directed against infection with human immunodeficiency virus, by enhancing antiviral resistance of target cells through the constitutive production of autocrine interferon (IFN). Using the human IFN-beta coding sequence under the constitutive low-expression control of a 0.6-kb murine H-2Kb promoter-fragment, we have constructed a retroviral vector, HMB-KbHuIFN beta, and have transformed cells of the T98G human neuroblastoma line, the U-937 human promonocytic line, and the CEM human lymphocytic line. These human IFN-beta-transformed cell populations have acquired a low, constitutive production of human IFN, while replicating at a rate similar to that of untransformed cells and of cells transformed with the control vector carrying a human IFN-beta sequence encoding an inactive, mutated protein. In the three different cell populations tested, transformation with the HMB-KbHuIFN beta vector resulted in a 1.3-2.3 log10 reduction in the number of cells infected with a defective amphotropic MFG-LaZ retrovirus. A kinetic study of the fate of the MFG-LacZ retrovirus in the culture medium and intracellularly immediately after exposure of the cells to virus revealed a significant reduction of the appearance of intracellular virus in human IFN-beta-transformed cells. A similar effect was obtained by treating untransformed T98G, U-937, and CEM cells with exogenous human IFN-beta. The blocking effect of autocrine or exogenous human IFN-beta on viral entry was not limited to virus specific for the amphotropic receptor but was also obtained in murine IFN-beta-treated NIH 3T3 mouse fibroblasts infected with an ecotropic MFG-LacZ retrovirus. Infection of human IFN-beta-transformed CEM cells with human immunodeficiency virus type 1 gave comparable results. Immediately following exposure of the cells to human immunodeficiency virus, a kinetic study of the fate of the virus failed to reveal the appearance of intracellular virus and showed that the majority of the input virus remained in the extracellular medium. We conclude that low autocrine IFN-beta synthesis, or exposure of cells to exogenous IFN-beta, prevents virus from getting inside the cells, regardless of the virus receptor involved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511818      PMCID: PMC43435          DOI: 10.1073/pnas.91.7.2689

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

2.  Changes in fatty acyl chains of phospholipids induced by interferon in mouse sarcoma S-180 cells.

Authors:  K Chandrabose; P Cuatrecasas; R Pottathil
Journal:  Biochem Biophys Res Commun       Date:  1981-02-12       Impact factor: 3.575

3.  Interferon inhibits Sendai virus-induced cell fusion: an effect on cell membrane fluidity.

Authors:  S Chatterjee; H C Cheung; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

4.  The inhibitory effect of interferon on a temperature-sensitive mutant of Moloney murine leukemia virus.

Authors:  E H Chang; M W Myers; P K Wong; R M Friedman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

5.  Rapid purification of extracellular and intracellular Moloney murine leukemia virus.

Authors:  M Aboud; M Wolfson; Y Hassan; M Huleihel
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  An effect of interferon on the uncoating of murine leukaemia virus not related to the antiviral state.

Authors:  M Aboud; R Shoor; S Salzberg
Journal:  J Gen Virol       Date:  1980-12       Impact factor: 3.891

7.  Interferon increases the abundance of submembranous microfilaments in HeLa-S3 cells in suspension culture.

Authors:  E Wang; L M Pfeffer; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

8.  Beta-interferon-induced time-dependent changes in the plasma membrane lipid bilayer of cultured cells.

Authors:  L M Pfeffer; F R Landsberger; I Tamm
Journal:  J Interferon Res       Date:  1981

9.  Interferon effects on microfilament organization, cellular fibronectin distribution, and cell motility in human fibroblasts.

Authors:  L M Pfeffer; E Wang; I Tamm
Journal:  J Cell Biol       Date:  1980-04       Impact factor: 10.539

10.  Interferon inhibits the redistribution of cell surface components.

Authors:  L M Pfeffer; E Wang; I Tamm
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Gene therapy for HIV.

Authors:  A M Lever
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

2.  Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens.

Authors:  V Vieillard; I Cremer; E Lauret; W Rozenbaum; P Debré; B Autran; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.

Authors:  G Herbein; L J Montaner; S Gordon
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.

Authors:  Caroline Goujon; Michael H Malim
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

5.  Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.

Authors:  V Vieillard; S Jouveshomme; N Leflour; E Jean-Pierre; P Debre; E De Maeyer; B Autran
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.

Authors:  I Bahner; K Kearns; Q L Hao; E M Smogorzewska; D B Kohn
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Regulation of human immunodeficiency virus replication by 2',5'-oligoadenylate-dependent RNase L.

Authors:  R K Maitra; R H Silverman
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Retroviral-mediated gene transfer in primary murine and human T-lymphocytes.

Authors:  I Rivière; H F Gallardo; A B Hagani; M Sadelain
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

9.  A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Weiming Wang; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

10.  Anti-human immunodeficiency virus activity of tau interferon in human macrophages: involvement of cellular factors and beta-chemokines.

Authors:  Christine Rogez; Marc Martin; Nathalie Dereuddre-Bosquet; Jacques Martal; Dominique Dormont; Pascal Clayette
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.